The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequent germline BRCA1/2 mutations in women with ovarian cancer and the need for insurance coverage of genetic testing: A Hellenic Society of Medical Oncology (HeSMO) national program.
 
Georgios Lypas
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; LEO Pharma; Roche
 
Zacharenia Saridaki
No Relationships to Disclose
 
Emmanouil S. Saloustros
No Relationships to Disclose
 
Michael Liontos
No Relationships to Disclose
 
Evangelos Bournakis
No Relationships to Disclose
 
Christos Papandreou
No Relationships to Disclose
 
Evangelos Lianos
No Relationships to Disclose
 
Haralabos Kalofonos
No Relationships to Disclose
 
Elena Maragouli
No Relationships to Disclose
 
Gerasimos Aravantinos
No Relationships to Disclose
 
Nikolaos Xenidis
No Relationships to Disclose
 
Charalampos Andreadis
No Relationships to Disclose
 
Eleni Stergiou
No Relationships to Disclose
 
Alexandros Bokas
No Relationships to Disclose
 
Cedric Gouedard
No Relationships to Disclose
 
George Nasioulas
No Relationships to Disclose
 
Fotini Papageorgiou
Employment - AstraZeneca
 
Athanasios Athanasiadis
No Relationships to Disclose
 
Ioannis Varthalitis
No Relationships to Disclose
 
Ioannis Boukovinas
Employment - Novartis Pharmaceuticals UK Ltd. (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; LEO Pharma; MSD; Novartis; Roche; Sanofi
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pfizer; Roche